Interest Successfully AddedWe'll notify you here with news aboutTurn on desktop notifications for breaking stories about interest? OffOnThe drug, called daraxonrasib, will be sold under the brand name Rasonque.August 26, 2026, 11:44 AMThe Food and Drug Administration approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer.The drug, called daraxonrasib, will be sold under the brand name Rasonque. The daily pill targets multiple forms of a protein called RAS, which is a main driver of tumor growth.Popular ReadsThis is a developing story. Please check back for updates.Popular Reads24/7 coverage of breaking news and live events